92眼改良骨-牙-角膜假体手术后玻璃体视网膜并发症及结局的10年回顾
该回顾性病例系列分析了2003年3月至2013年2月在一家三级眼科中心接受改良骨-牙-角膜假体(mOOKP)手术的92眼(90例患者)的玻璃体视网膜并发症及治疗结局。41眼(39例)发生玻璃体视网膜并发症,从mOOKP手术到并发症发生的平均间隔为43.8个月。结论认为玻璃体视网膜并发症是mOOKP术后视力损害的重要原因,但适当和及时干预可获得令人鼓舞的结果。
要点
- 92眼mOOKP手术中41眼(39例)发生玻璃体视网膜并发症,最常见为玻璃体炎(21眼)。
- 从mOOKP手术到玻璃体视网膜并发症发生的平均间隔为43.8个月(中位数41.9个月,范围0.2-95.5个月)。
- 治疗后17眼(42%)视力改善,7眼(14%)视力下降,17眼(42%)视力无变化;最终BCVA≥6/60者19眼,≥6/18者9眼。
核心结论
- 玻璃体视网膜并发症是mOOKP术后视力损害的重要原因,处理具有挑战性,但适当和及时干预可获得令人鼓舞的结果。
研究设计与样本
- 回顾性病例系列,纳入2003年3月至2013年2月在一家三级眼科中心接受mOOKP手术的所有患者,共92眼(90例患者)。
主要发现
- mOOKP适应证包括Stevens-Johnson综合征(53眼)、化学伤(36眼)和眼瘢痕性类天疱疮(3眼)。
- 41眼(39例)发生玻璃体视网膜并发症:玻璃体炎21眼、视网膜脱离12眼(其中原发性5眼)、假体后膜10眼(其中原发性2眼)、眼内炎8眼、玻璃体积血5眼(其中原发性1眼)、浆液性脉络膜脱离5眼、出血性脉络膜脱离2眼、渗漏相关低眼压1眼。
- 从mOOKP手术到玻璃体视网膜并发症发生的平均间隔为43.8个月(中位数41.9个月,范围0.2-95.5个月)。
- 玻璃体视网膜并发症治疗后,17眼(42%)视力改善(平均改善1.2 logMAR,中位数0.8 logMAR,范围0.1-2.5 logMAR),7眼(14%)视力下降(平均下降0.6 logMAR,中位数0.4 logMAR,范围0.3-1.8 logMAR),17眼(42%)视力无变化。
- 最终玻璃体视网膜治疗后,BCVA≥6/60者保留19眼,BCVA≥6/18者保留9眼。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze vitreoretinal (VR) complications and treatment outcomes in eyes undergoing modified osteo-odonto-keratoprosthesis (OOKP) surgery. DESIGN: Retrospective case series. PARTICIPANTS: All patients who underwent modified OOKP (mOOKP) surgery at a tertiary eye-care center from March 2003 to February 2013 were included. METHODS: Medical records were reviewed for relevant medical history, best-corrected visual acuity (BCVA), slit-lamp examination, ultrasound scan, oral examination findings, and VR complications. MAIN OUTCOME MEASURES: The BCVA at the last visit. Optimal anatomic outcome was attached retina with a normal intraocular pressure at the last visit. RESULTS: A total of 92 eyes of 90 patients were included. Indications for OOKP included Stevens-Johnson syndrome (n = 53), chemical injury (n = 36), and ocular cicatricial pemphigoid (n = 3). A total of 41 eyes of 39 patients developed VR complications, including vitritis (n = 21), retinal detachment (RD) (n = 12; primary RD = 5), retroprosthetic membrane (RPM) (n = 10; primary RPM = 2), endophthalmitis (n = 8), vitreous hemorrhage (VH) (n = 5; primary VH = 1), serous choroidal detachment (n = 5), hemorrhagic choroidal detachment (n = 2), and leak-related hypotony (n = 1). Mean interval from mOOKP surgery to occurrence of VR complication(s) was 43.8 months (median, 41.9 months; range, 0.2-95.5 months). After treatment of VR complication, visual improvement was seen in 17 eyes (42%) (mean improvement = 1.2 logarithm of the minimum angle of resolution [logMAR]; median, 0.8 logMAR; range, 0.1-2.5 logMAR), visual decline in 7 eyes (14%) (mean decline in BCVA = 0.6 logMAR; median, 0.4 logMAR; range, 0.3-1.8 logMAR), and no change in BCVA in 17 eyes (42%). However, BCVA ≥6/60 was retained in 19 eyes and ≥6/18 was retained in 9 eyes after final VR treatment. CONCLUSIONS: Vitreoretinal complications constitute a significant cause of visual morbidity in eyes undergoing mOOKP surgery and pose a challenging situation to manage. However, appropriate and timely intervention can achieve encouraging results.
引用
- Rishi P, Rishi E, Agarwal V, et al. Vitreoretinal Complications and Outcomes in 92 Eyes Undergoing Surgery for Modified Osteo-Odonto-Keratoprosthesis: A 10-Year Review. Ophthalmology. 2018. PMID: 29342438. doi:10.1016/j.ophtha.2017.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。